Ā | Control Group (nĀ =ā129) | E-pathway Group (nĀ =ā52) | P-value |
---|---|---|---|
Age, mean (SD) | 84.9 (5.9) | 82.8 (7.2) | 0.036 |
Sex, n (%) | |||
āMale | 35 (27.1%) | 14 (27.0%) | Ā |
āFemale | 94 (72.9%) | 38 (73.0%) | 0.977 |
Living Status Before Admission, n (%) | |||
āHome | 74 (57.4%) | 33 (63.5%) | Ā |
āCare Facility/Residential Aged Care | 55 (42.6%) | 19 (36.5%) | 0.086 |
Fracture Type, n (%) | |||
āIntracapsular | 63 (48.8%) | 20 (38.0%) | Ā |
āIntertrochanteric | 55 (42.6%) | 13 (25.0%) | Ā |
āSubtrochanteric | 10 (8.8%) | 2 (4.0%) | Ā |
āUnknown | 1 (0.8%) | 17 (33.0%) | 0.695 |
Type of Surgery, n (%) | |||
āInternal Fixation (cannulated screws) | 3 (2.3%) | 4 (8.0%) | Ā |
āHemiarthroplasty | 45 (34.9%) | 21 (40.0%) | Ā |
āTotal Hip Replacement | 53 (41.1%) | 14 (27.0%) | Ā |
āSliding Hip Screws/DHS | 27 (20.9%) | 8 (15.0%) | Ā |
āIntramedullary Nails/Gamma | 1 (0.8%) | 0 (0.0%) | Ā |
āOther | 0 (0.0%) | 5 (10.0%) | 0.201 |
eGFR, mean (SD) | 50.7 (11.7) | 66.4 (18.8) | <ā0.001 |